Management of breast cancer--Part II.
Turner
Nicholas C
NC
Department of Medical Oncology, Royal Free Hospital NHS Foundation Trust, London NW3 2QG. nicholas.turner@icr.ac.uk
Jones
Alison L
AL
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D047072:Aromatase Inhibitors / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000145:classification / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D020360:Neoadjuvant Therapy; D009362:Neoplasm Metastasis / Q000188:drug therapy; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy; D013629:Tamoxifen / Q000627:therapeutic use; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018931:Antineoplastic Agents, Hormonal; D047072:Aromatase Inhibitors; D013629:Tamoxifen; D000068878:Trastuzumab